Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in AGIO — Agios Pharmaceuticals, Inc.

CIK 1423053 MIAMI, FL
Back to AGIO Full portfolio

Position in AGIO

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$27,190,013
+$6,228,507 QoQ
Shares Held
732,687
+18.2% QoQ
Ownership
1.23%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#23
of 238 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AGIO Over Time

Shares Held

Position Value (USD)

Derivatives in AGIO

reported options exposure · as of Jun 30, 2026
CallValue
$3,402,987
CallShares
91,700
PutValue
$3,295,368
PutShares
88,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,150,763,744 across 435 Biotechnology names. AGIO ranks #47 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
 3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
 1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in AGIO

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $27,190,013 732,687
2026-06-30 $3,402,987 91,700
2026-06-30 $3,295,368 88,800
2026-03-31 $2,845,103 84,100
2026-03-31 $2,222,631 65,700
2026-03-31 $20,961,506 619,613
2025-12-31 $1,366,444 50,200
2025-12-31 $5,708,034 209,700
2025-12-31 $36,718,908 1,348,968
2025-09-30 $1,553,418 38,700
2025-09-30 $2,982,402 74,300
2025-09-30 $19,748,157 491,982
2025-06-30 $1,107,558 33,300
2025-06-30 $1,024,408 30,800
2025-06-30 $35,969,691 1,081,470
2025-03-31 $1,344,870 45,900
2025-03-31 $25,300,520 863,499
2025-03-31 $747,150 25,500
2024-12-31 $308,884 9,400
2024-12-31 $47,110,592 1,433,676
2024-12-31 $1,245,394 37,900
2024-09-30 $521,430 11,736
2024-09-30 $564,261 12,700
2024-09-30 $670,893 15,100
2024-06-30 $655,424 15,200
2024-06-30 $5,339,980 123,840
2024-06-30 $901,208 20,900
2024-03-31 $894,744 30,600
2024-03-31 $289,476 9,900
2024-03-31 $29,311,959 1,002,461
2023-12-31 $23,936,062 1,074,812
2023-12-31 $115,804 5,200
2023-12-31 $249,424 11,200
2023-09-30 $10,311,295 416,618
2023-09-30 $502,425 20,300
2023-09-30 $376,200 15,200
2023-06-30 $419,136 14,800
2023-06-30 $4,961,408 175,191
2023-06-30 $260,544 9,200
2023-03-31 $6,504,046 283,154
2023-03-31 $771,792 33,600
2023-03-31 $96,474 4,200
2022-12-31 $892,944 31,800
2022-12-31 $862,056 30,700
2022-12-31 $6,149,997 219,017
2022-09-30 $7,060,157 249,652
2022-09-30 $1,561,056 55,200
2022-09-30 $1,894,760 67,000
2022-06-30 $7,395,489 333,581
2022-06-30 $547,599 24,700